American Psychedelic Practitioners Association

The medical psychedelics field stands at a pivotal juncture. With MDMA-assisted therapy close to federal legalization for the treatment of PTSD in the U.S. and other psychedelic substances potentially following suit, these therapies are poised to revolutionize treatment for certain mental health...

The American Psychedelic Practitioners Association (APPA), a federal organization with the goal of safely integrating psychedelics into the U.S. healthcare system, has retained The Daschle Group as governmental affairs counsel.  See Also: A New Accreditation Model For Psychedelic Practitioners...

First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published The American Psychedelic Practitioners Association (APPA) and BrainFutures have published the first-ever set of professional practice guidelines for the provision of psychedelic-assisted therapy. APPA is the...

The American Psychedelic Practitioners Association (APPA) and BrainFutures have published reportedly the first-ever set of professional practice guidelines for the provision of psychedelic-assisted therapy. APPA is the national entity advocating for the...

GOP-Controlled House Committee Blocks All Cannabis & Psychedelics Amendments To Defense Bill: Now, No Floor Vote Not a single drug policy amendment that was proposed by a group of bipartisan lawmakers as part of the National Defense Authorization Act (NDAA) passed on Thursday. Republican...

The newly-appointed executive director of the American Psychedelic Practitioners Association (APPA,) Ret. Brigadier General Dr. Stephen Xenakis, recently spoke to Benzinga about the organization’s projects concerning the incoming landscape of legal psychedelic-assisted therapies (PAT) and the...

At the MAPS 2023 conference, Benzinga spoke with Brigadier General (R) Dr. Stephen Xenakis, the executive director of the American Psychedelic Practitioners Association (APPA,) who has worked with Physicians for Human Rights and Human Rights First and in Guantanamo and refugee camps. Brigadier...

Palo Santo Closes $50M Investment Fund Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million fund. “Against the backdrop of a growing global mental health crisis, our mission is to...

The current state of affairs seems to show that psychedelics-assisted therapy will eventually become part of the healthcare system for those suffering from a diverse range of mental and physical disorders, with most recent and noticeable examples in Alberta, Canada and Oregon. Newly...